Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O0HU
|
|||
| Former ID |
DIB006008
|
|||
| Drug Name |
LAS-41007
|
|||
| Synonyms |
Dermatological agent (topical, actinic keratosis), Almirall
Click to Show/Hide
|
|||
| Indication | Keratosis [ICD-11: ED56; ICD-10: L57.0] | Phase 3 | [1] | |
| Company |
Almirall Prodesfarma SA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01265602) Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.